Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation.

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Citi initiated coverage of Moderna (MRNA) with a Neutral rating and $40 price target Healthcare policy remains a key biopharma sector ...

Solano County issued a countywide Shelter at Home Health Order and Directive to continue protecting the health and safety of ...

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

If Medicaid is taken away, children could still receive vaccination coverage through a variety of other programs, including the Children's Health Insurance Program or the Title V Maternal and Child ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Both Switzerland and the Nordic Countries have announced their artist selections for the 2026 Venice Biennale (9 May-22 ...

WASHINGTON: The White House withdrew President Donald Trump's nomination of former Republican congressman and vaccine critic ...

Convincing professionals, software engineers and other application developers to open their wallets for new artificial ...

NPR reports on the National Institutes of Health funding cuts with insight from two NIH staffers and one person familiar with NIH's activities who requested anonymity because they were not authorized ...